Secreted BMP antagonists and their role in cancer and bone metastases
- 28 May 2020
- journal article
- review article
- Published by Elsevier BV in Bone
- Vol. 137, 115455
- https://doi.org/10.1016/j.bone.2020.115455
Abstract
No abstract availableKeywords
This publication has 156 references indexed in Scilit:
- Bone Morphogenetic Protein Type I Receptor Antagonists Decrease Growth and Induce Cell Death of Lung Cancer Cell LinesPLOS ONE, 2013
- Bone morphogenetic protein modulator BMPER is highly expressed in malignant tumors and controls invasive cell behaviorOncogene, 2011
- Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinomaOncogene, 2010
- Induction of follistatin precedes gastric transformation in gastrin deficient miceBiochemical and Biophysical Research Communications, 2008
- The CCN family of proteins: structure–function relationshipsTrends in Biochemical Sciences, 2008
- Crossveinless-2 Is a BMP Feedback Inhibitor that Binds Chordin/BMP to Regulate Xenopus Embryonic PatterningDevelopmental Cell, 2008
- Aggressive melanoma cells escape from BMP7-mediated autocrine growth inhibition through coordinated Noggin upregulationLaboratory Investigation, 2008
- Soluble hemojuvelin is released by proprotein convertase-mediated cleavage at a conserved polybasic RNRR siteBlood Cells, Molecules, and Diseases, 2008
- Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferationProceedings of the National Academy of Sciences of the United States of America, 2006
- Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterningNature Genetics, 2003